Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)
Clinical trial NCT06621459 · RECRUITING
Trial details
- NCT number
- NCT06621459
- Sponsor
- University Hospital, Brest
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-26
- Primary completion
- 2025-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.